Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.
Ring, J; Worm, M; Wollenberg, A; Thyssen, J P; Jakob, T; Klimek, L; Bangert, C; Barbarot, S; Bieber, T; de Bruin-Weller, M S; Chernyshov, P V; Christen-Zaech, S; Cork, M; Darsow, U; Flohr, C; Fölster-Holst, R; Gelmetti, C; Gieler, U; Gutermuth, J; Heratizadeh, A; Hijnen, D J; von Kobyletzki, L B; Kunz, B; Paul, C; De Raeve, L; Seneschal, J; Simon, D; Spuls, P I; Stalder, J F; Svensson, A; Szalai, Z; Taieb, A; Torrelo, A; Trzeciak, M; Vestergaard, C; Werfel, T; Weidinger, S; Deleuran, M.
J Eur Acad Dermatol Venereol ; 35(6): e362-e365, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1145311

Subject(s)
Anaphylaxis , COVID-19 , Dermatitis, Atopic , Vaccines , COVID-19 Vaccines , Dermatitis, Atopic/prevention & control , Humans , SARS-CoV-2
2.
Allergen-Immunotherapy in the current Covid-19 Pandemic Position Paper of the German ARIA-Group in Cooperation with the Austrian ARIA-Group, the Swiss ARIA-Group, the Medical Association of German Allergologists (AeDA), the German Society for Allergology and clinical Immunology (DGAKI) and the Society for Pediatric Allergology and Environmental Medicine (GPA ) in Cooperation with the AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHC and the European Academy for Allergology and clinical Immunology (EAACI)
Klimek, L.; Pfaar, O.; Worm, M.; Bergmann, K. C.; Bieber, T.; Buhl, R.; Buters, J.; Darsow, U.; Keil, T.; Kleine-Tebbe, J.; Lau, S.; Maurer, M.; Merk, H.; Mosges, R.; Saloga, J.; Staubach, P.; Stute, P.; Rabe, K.; Rabe, U.; Vogelmeier, C.; Biedermann, T.; Jung, K.; Schlenter, W.; Ring, J.; Chaker, A.; Wehrmann, W.; Becker, S.; Mulleneisen, N.; Nemat, K.; Czech, W.; Wrede, H.; Brehler, R.; Fuchs, T.; Tomazic, P. V.; Aberer, W.; Fink-Wagner, A.; Horak, F.; Wohrl, S.; NiederbergerLeppin, V.; Pali-Scholl, I.; Pohl, W.; Roller-Wirnsberger, R.; Spranger, O.; Valenta, R.; Akdis, M.; Akdis, C.; Hoffmann-Sommergruber, K.; Jutel, M.; Matricardi, P.; Spertini, F.; Khaltaev, N.; Michel, J. P.; Nicod, L.; Schmid-Grendelmeier, P.; Hamelmann, E.; Jakob, T.; Werfel, T.; Wagenmann, M.; Taube, C.; Gerstlauer, M.; Vogelberg, C.; Bousquet, J.; Zuberbier, T..
Allergo Journal ; 29(3):17-25, 2020.
Article in German | Web of Science | ID: covidwho-1089121
3.
Management of Patients at Risk of Anaphylaxis during the Covid-19 Pandemic A Position Paper by the Medical Association of German Allergologists (AeDA), the German Society for Allergology and clinical Immunology (DGAKI), the Society for Pediatric Allergology and Environmental Medicine (GPA) and the German Allergy- and Asthma Association (DAAB)
Klimek, L.; Worm, M.; Lange, L.; Beyer, K.; Rietschel, E.; Vogelberg, C.; Schnadt, S.; Stocker, B.; Brockow, K.; Hagemann, J.; Bieber, T.; Wehrmann, W.; Becker, S.; Freudelsperger, L.; Mulleneisen, N.; Nemat, K.; Czech, W.; Wrede, H.; Brehler, R.; Fuchs, T.; Dramburg, S.; Matricardi, P.; Hamelmann, E.; Werfel, T.; Wagenmann, M.; Taube, C.; Zuberbier, T.; Ring, J..
Allergo Journal ; 29(7):16-26, 2020.
Article in English | Web of Science | ID: covidwho-1080023
4.
Use of biologics in allergic and type 2 inflammatory diseases in the current Covid 19 pandemic(a, b, c)
Klimek, L.; Pfaar, O.; Worm, M.; Eiwegger, T.; Hagemann, J.; Ollert, M.; Untersmayr, E.; Hoffmann-Sommergruber, K.; Vultaggio, A.; Agache, I.; Bavbek, S.; Bossios, A.; Casper, I.; Chan, S. S.; Chatzipetrou, A.; Vogelberg, C.; Firinu, D.; Kauppi, P.; Kolios, A.; Kothari, A.; Matucci, A.; Palomares, O.; Szepfalusi, Z.; Pohl, W.; Hotzenecker, W.; Rosenkranz, A. R.; Bergmann, K. C.; Bieber, T.; Buhl, R.; Buters, J.; Darsow, U.; Keil, T.; Kleine-Tebbe, J.; Lau, S.; Maurer, M.; Merk, H.; Mosges, R.; Saloga, J.; Staubach, P.; Jappe, U.; Rabe, K. F.; Rabe, U.; Vogelmeier, C.; Biedermann, T.; Jung, K.; Schlenter, W.; Ringa, J.; Chaker, A.; Wehrmann, W.; Becker, S.; Freudelsperger, L.; Mulleneisen, N.; Nemat, K.; Czech, W.; Wrede, H.; Brehler, R.; Fuchs, T.; Tomazic, P. V.; Aberer, W.; Fink-Wagner, A. H.; Horak, F.; Wohrl, S.; Niederberger-Leppin, V.; Pali-Scholl, I.; Pohlg, W.; Roller-Wirnsberger, R.; Spranger, O.; Valenta, R.; Akdis, M.; Matricardi, P. M.; Spertini, F.; Khaltaev, N.; Michel, J. P.; Nicod, L.; Schmid-Grendelmeier, P.; Idzko, M.; Hamelmann, E.; Jakob, T.; Werfel, T.; Wagenmann, M.; Taube, C.; Jensen-Jarolim, E.; Korn, S.; Hentges, F.; Schwarze, J.; O'Mahony, L.; Knol, E. F.; del Giacco, S.; Perez, T. C.; Bousquet, J.; Zuberbier, T.; Akdis, C.; Jutel, M..
Allergo Journal ; 29(4):14-27, 2020.
Article in English | Web of Science | ID: covidwho-1080022
5.
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics.
Thyssen, J P; Vestergaard, C; Barbarot, S; de Bruin-Weller, M S; Bieber, T; Taieb, A; Seneschal, J; Cork, M J; Paul, C; Flohr, C; Weidinger, S; Trzeciak, M; Werfel, T; Heratizadeh, A; Darsow, U; Simon, D; Torrelo, A; Chernyshov, P V; Stalder, J-F; Gelmetti, C; Szalai, Z; Svensson, Å; von Kobyletzki, L B; De Raeve, L; Fölster-Holst, R; Christen-Zaech, S; Hijnen, D J; Gieler, U; Gutermuth, J; Bangert, C; Spuls, P I; Kunz, B; Ring, J; Wollenberg, A; Deleuran, M.
J Eur Acad Dermatol Venereol ; 35(5): e308-e311, 2021 May.
Article in English | MEDLINE | ID: covidwho-1084257

Subject(s)
Biological Products , COVID-19 , Dermatitis, Atopic , Adult , Dermatitis, Atopic/drug therapy , Humans , SARS-CoV-2 , Vaccination
6.
Interferon-beta as an enhancer of paraviral exanthema during influenza virus infection.
Braegelmann, C; Niebel, D; Wenzel, J; Bieber, T; Eis-Hübinger, A M; Wilsmann-Theis, D.
J Eur Acad Dermatol Venereol ; 35(3): e228-e230, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-796096

Subject(s)
Communicable Diseases , Exanthema , Influenza, Human , Humans , Interferon-beta
7.
[Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)]. / Allergen-Immuntherapie in der aktuellen COVID-19-Pandemie ­ ein Positionspapier von ARIA, EAACI, AeDA, GPA und DGAKI (Kurzversion) ­ Positionspapier der deutschen ARIA-GruppeA in Kooperation mit der österreichischen ARIA-GruppeB, der schweizerischen ARIA-GruppeC, dem Ärzteverband Deutscher Allergologen (AeDA)D, der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)E und der Gesellschaft für Pädiatrische Allergologie (GPA)F in Kooperation mit der AG Klinische Immunologie, Allergologie und Umweltmedizin der DGHNO-KHCG und der Europäischen Akademie für Allergologie und Klinische Immunologie (EAACI)H.
Pfaar, O; Klimek, L; Worm, M; Bergmann, K-C; Bieber, T; Buhl, R; Buters, J; Darsow, U; Keil, T; Kleine-Tebbe, J; Lau, S; Maurer, M; Merk, H; Mösges, R; Saloga, J; Staubach, P; Stute, P; Rabe, K; Rabe, U; Vogelmeier, C; Biedermann, T; Jung, K; Schlenter, W; Ring, J; Chaker, A; Wehrmann, W; Becker, S; Mülleneisen, N; Nemat, K; Czech, W; Wrede, H; Brehler, R; Fuchs, T; Tomazic, P-V; Aberer, W; Fink-Wagner, A; Horak, F; Wöhrl, S; Niederberger-Leppin, V; Pali-Schöll, I; Pohl, W; Roller-Wirnsberger, R; Spranger, O; Valenta, R; Akdis, M; Akdis, C; Hoffmann-Sommergruber, K; Jutel, M; Matricardi, P; Spertini, F.
Laryngorhinootologie ; 99(10): 676-679, 2020 10.
Article in German | MEDLINE | ID: covidwho-726949

Subject(s)
Betacoronavirus , Coronavirus Infections , Pandemics , Pneumonia, Viral , COVID-19 , Desensitization, Immunologic , Humans , SARS-CoV-2
8.
Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic
Klimek, L.; Pfaar, O.; Worm, M.; Eiwegger, T.; Hagemann, J.; Ollert, M.; Untersmayr, E.; Hoffmann-Sommergruber, K.; Vultaggio, A.; Agache, I.; Bavbek, S.; Bossios, A.; Casper, I.; Chan, S.; Chatzipetrou, A.; Vogelberg, C.; Firinu, D.; Kauppi, P.; Kolios, A.; Kothari, A.; Matucci, A.; Palomares, O.; Szépfalusi, Z.; Pohl, W.; Hötzenecker, W.; Rosenkranz, A. R.; Bergmann, K. C.; Bieber, T.; Buhl, R.; Buters, J.; Darsow, U.; Keil, T.; Kleine-Tebbe, J.; Lau, S.; Maurer, M.; Merk, H.; Mösges, R.; Saloga, J.; Staubach, P.; Jappe, U.; Rabe, K. F.; Rabe, U.; Vogelmeier, C.; Biedermann, T.; Jung, K.; Schlenter, W.; Ring, J.; Chaker, A.; Wehrmann, W.; Becker, S.; Freudelsperger, L.; Mülleneisen, N.; Nemat, K.; Czech, W.; Wrede, H.; Brehler, R.; Fuchs, T.; Tomazic, P. V.; Aberer, W.; Fink-Wagner, A. H.; Horak, F.; Wöhrl, S.; Niederberger-Leppin, V.; Pali-Schöll, I.; Pohl, W.; Roller-Wirnsberger, R.; Spranger, O.; Valenta, R.; Akdis, M.; Matricardi, P. M.; Spertini, F.; Khaltaev, N.; Michel, J. P.; Nicod, L.; Schmid-Grendelmeier, P.; Idzko, M.; Hamelmann, E.; Jakob, T.; Werfel, T.; Wagenmann, M.; Taube, C.; Jensen-Jarolim, E.; Korn, S.; Hentges, F.; Schwarze, J.; Mahony, L.; Knol, E. F.; del Giacco, S.; Chivato Pérez, T.; Bousquet, J.; Zuberbier, T.; Akdis, C.; Jutel, M..
Allergologie ; 7(43):255-271, 2020.
Article | ELSEVIER | ID: covidwho-679467
9.
European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis.
Wollenberg, A; Flohr, C; Simon, D; Cork, M J; Thyssen, J P; Bieber, T; de Bruin-Weller, M S; Weidinger, S; Deleuran, M; Taieb, A; Paul, C; Trzeciak, M; Werfel, T; Seneschal, J; Barbarot, S; Darsow, U; Torrelo, A; Stalder, J-F; Svensson, Å; Hijnen, D; Gelmetti, C; Szalai, Z; Gieler, U; De Raeve, L; Kunz, B; Spuls, P; von Kobyletzki, L B; Fölster-Holst, R; Chernyshov, P V; Christen-Zaech, S; Heratizadeh, A; Ring, J; Vestergaard, C.
J Eur Acad Dermatol Venereol ; 34(6): e241-e242, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-630505

Subject(s)
Coronavirus Infections/epidemiology , Dermatitis, Atopic/epidemiology , Immunosuppressive Agents/therapeutic use , Pneumonia, Viral/epidemiology , Practice Guidelines as Topic , Severe Acute Respiratory Syndrome/epidemiology , Advisory Committees , COVID-19 , Comorbidity , Coronavirus Infections/immunology , Dermatitis, Atopic/drug therapy , Dermatitis, Atopic/immunology , Europe , Female , Humans , Immunocompromised Host/drug effects , Male , Pandemics , Pneumonia, Viral/immunology , Risk Assessment , Severe Acute Respiratory Syndrome/immunology , Treatment Outcome
10.
Allergen immunotherapy in the current COVID-19 pandemic - A position paper of the AeDA, ARIA, EAACI, DGAKI and GPA
Klimek, L.; Pfaar, O.; Worm, M.; Bergmann, K. C.; Bieber, T.; Buhl, R.; Buters, J.; Darsow, U.; Keil, T.; Kleine-Tebbe, J.; Lau, S.; Maurer, M.; Merk, H.; Mösges, R.; Saloga, J.; Staubach, P.; Stute, P.; Rabe, K.; Rabe, U.; Vogelmeier, C.; Biedermann, T.; Jung, K.; Schlenter, W.; Ring, J.; Chaker, A.; Wehrmann, W.; Becker, S.; Mülleneisen, N.; Nemat, K.; Czech, W.; Wrede, H.; Brehler, R.; Fuchs, T.; Tomazic, P. V.; Aberer, W.; Fink-Wagner, A.; Horak, F.; Wöhrl, S.; Niederberger-Leppin, V.; Pali-Schöll, I.; Pohl, W.; Roller-Wirnsberger, R.; Spranger, O.; Valenta, R.; Akdis, M.; Akdis, C.; Hoffmann-Sommergruber, K.; Jutel, M.; Matricardi, P.; Spertini, F.; Khaltaev, N.; Michel, J. P.; Nicod, L.; Schmid-Grendelmeier, P.; Hamelmann, E.; Jakob, T.; Werfel, T.; Wagenmann, M.; Taube, C.; Gerstlauer, M.; Vogelberg, C.; Bousquet, J.; Zuberbier, T..
Allergologie ; 43(5):165-175, 2020.
Article in German | EMBASE | ID: covidwho-621736
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL